William B. Ershler, Md

This study tested a drug called thymalfasin (Ta1) to see if it could prevent COVID-19 infection in people with kidney failure who are on dialysis. These patients are at high risk because they spend time in dialysis centers and often have weak immune systems. The study involved 18…